||This article includes a list of references, but its sources remain unclear because it has insufficient inline citations. (February 2013)|
Professor Steven E. Hyman, MD, is Director of the Stanley Center for Psychiatric Research and a core member at the Broad Institute of MIT and Harvard. He is also Harvard University Distinguished Service Professor of Stem Cell and Regenerative Biology. The goal of the Stanley Center is decrease the burden of serious neuropsychiatric disorders through research. Scientists within the Center use large scale platforms in genetics <1>, stem cell biology, and other areas of biology and chemistry to gain better understanding of the neurobiological underpinnings of schizophrenia, bipolar disorder, autism, and other neurodevelopmental disorders and most critically to develop new directions in therapeutics after a long period of stagnation. Hyman was Provost of Harvard University from 2001 to 2011. As Provost, he was instrumental in the development of cross school and regional interdisciplinary initiatives, especially in the sciences. In 2009 he initiated an extensive process of reform of the Harvard libraries, the world's largest university library system with major goals that included support for technical innovation in research and teaching and for open access to academic work. He has been important in the creation of an open access mandate at Harvard.
From 1996 to 2001 Hyman was the Director of the National Institute of Mental Health (NIMH), one of the National Institutes of Health (NIH), a group of agencies that fund and perform biomedical research. NIMH supports neuroscience and the knowledge needed to understand, diagnose, and treat brain disorders. He has worked, more recently to open psychiatric classifications, including the Diagnostic and Statistical Manual of Mental Disorders (DSM) and the International Classification of Diseases, Mental and Behavioral Disorders to fundamental rethinking including the incorporation of neuroscience and genetics the recognition that many mental disorders are quantitative deviations from health rather than categorically different.
Hyman is the incoming president (November 2014-2015) of the Society for Neuroscience which has approximately 40,000 members. He is a member of the Institute of Medicine (IOM) of the US National Academies where he serves on the governing Council, is a member of the board of health science policy and chairs the Forum on Neuroscience, which brings together government, industry, academia, and NGOs. He is a Fellow of the American Academy of Arts and Sciences, a Fellow of the American Association for the Advancement of Science, a Fellow of the American College of Neuropsychopharmacology, and a Distinguished Life Fellow of the American Psychiatric Association. He is a founder member of the International Neuroethics Society, serving as the first President of the Society from 2006 to 2014.
Dr. Hyman received his B.A. summa cum laude from Yale College; an M.A. from the University of Cambridge, which he attended as a Mellon fellow studying the history and philosophy of science; and his M.D. from Harvard Medical School. After an internship in medicine at Massachusetts General Hospital, a residency in psychiatry at McLean Hospital, and a clinical fellowship in neurology at MGH, he was a postdoctoral fellow at Harvard in molecular biology.
- Reardon S (2014). "Gene-hunt gain for mental health". Nature 511 (7510): 393. doi:10.1038/511393a. PMID 25056042.
- Mehta, Aalok (7 October 2008). "Neuroethics Q & A with Steven Hyman: What is Neuroethics?". The Dana Foundation. Retrieved 28 September 2014.
- "Scientific Leadership: Steven E. Hyman". The Broad Institute. Retrieved 21 May 2013.